Amphastar Pharmaceuticals Inc (AMPH)

CapEx to Revenue

4.67%

Quarterly · Period ending:

AMPH logo

AMPH CapEx to Revenue

Latest reported4.67%
AMPH Quarterly CapEx/Revenue (26.16% → 4.67%)
High-resolution chart · PNG

AMPH capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Amphastar Pharmaceuticals Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
4.6715%
5.5541%
4.5176%
2.7877%
6.0574%
6.2729%
6.6539%
7.3049%
3.3137%
5.1171%
5.3014%
5.6453%
6.2136%
6.7682%
4.6733%
4.6808%
4.8288%
5.1002%
5.6896%
6.4342%
5.6471%
7.3947%
9.7257%
6.7493%
12.6903%
9.4535%
10.086%
10.829%
12.1093%
18.6678%
10.6835%
16.7256%
17.2452%
21.1327%
16.7511%
19.7061%
9.666%
12.8234%
8.399%
10.434%
7.9344%
6.6469%
5.3568%
6.7514%
6.3878%
7.3392%
15.7954%
7.0657%
6.5874%
9.213%
7.0268%
7.6587%
5.5083%
12.1953%
26.1556%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.